TEVA PHARMACEUTICAL INDUSTRIES LIMITED Finite-Lived Patents, Gross
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) had Finite-Lived Patents, Gross of $21.01 billion as of 2017-12-31, per its 10-K filed 2018-02-12.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, before Accumulated Amortization
us-gaap:FiniteLivedPatentsGross · last filed 2018-02-12
- 2017-12-31: Finite-Lived Patents, Gross $21.01B.
- 2017-09-30: Finite-Lived Patents, Gross $21.84B.
- 2017-06-30: Finite-Lived Patents, Gross $20.46B.
- 2017-03-31: Finite-Lived Patents, Gross $18.07B.
| Period end | Finite-Lived Patents, Gross |
|---|---|
| 2017-12-31 | $21.01B 10-K · filed 2018-02-12 |
| 2017-09-30 | $21.84B 6-K · filed 2017-11-02 |
| 2017-06-30 | $20.46B 6-K · filed 2017-08-03 |
| 2017-03-31 | $18.07B 6-K · filed 2017-05-11 |
| 2016-12-31 | $18.18B 10-K · filed 2018-02-12 |
| 2016-09-30 | $27.64B 6-K · filed 2016-11-15 |
| 2015-12-31 | $9.05B 20-F · filed 2017-02-15 |
| 2014-12-31 | $9.61B 20-F · filed 2016-02-11 |
| 2013-12-31 | $10.04B 20-F · filed 2015-02-09 |
| 2012-12-31 | $9.98B 20-F · filed 2014-02-10 |